Curis
CRIS
#10981
Rank
A$0.96 M
Marketcap
A$0.50
Share price
-17.89%
Change (1 day)
-81.43%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$61.1 Million, an increase over its 2023 earnings that were of -A$64.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-16.67%
2024 -A$61.1 Million-5.77%
2023 -A$64.84 Million-13.1%
2022 -A$74.61 Million27.52%
2021 -A$58.51 Million65.09%
2020 -A$35.45 Million-9.1%
2019 -A$38.99 Million-4.73%
2018 -A$40.93 Million-41.95%
2017 -A$70.49 Million-14.37%
2016 -A$82.32 Million3.55%
2015 -A$79.5 Million271.52%
2014 -A$21.4 Million76.64%
2013 -A$12.12 Million
2011 -A$10.29 Million27.76%
2010 -A$8.06 Million-43.87%
2009 -A$14.35 Million-23.44%
2008 -A$18.74 Million56.66%
2007 -A$11.97 Million-16.71%
2006 -A$14.37 Million-36.92%
2005 -A$22.77 Million156.25%
2004 -A$8.89 Million-37.24%
2003 -A$14.16 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.12 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.70 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$88.39 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.43 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.37 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA